Quantum Genomics Société Anonyme (EPA:ALQGC)

EPA:ALQGC Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.3	3.55	10.4	13.55	27.15
Short-Term Investments	-	-	-	0.26	0.29
Cash & Short-Term Investments	0.3	3.55	10.4	13.81	27.44
Cash Growth	-91.51%	-65.89%	-24.68%	-49.67%	141.36%
Accounts Receivable	-	-	-	0.7	0.74
Other Receivables	0.03	0.12	12.9	3.19	2.9
Receivables	0.03	0.12	12.9	3.88	3.64
Prepaid Expenses	0.02	0.02	0.09	-	-
Other Current Assets	0	0	0	2.54	0.75
Total Current Assets	0.35	3.69	23.39	20.23	31.83
Property, Plant & Equipment	0	0.01	0.02	0.44	0.18
Long-Term Investments	-	0.04	0.21	-	-
Other Intangible Assets	-	-	-	0.54	0.76
Other Long-Term Assets	0	0.01	0.03	0.03	0.03
Total Assets	0.35	3.75	23.66	21.24	32.8

Liabilities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	0.15	0.27	16.01	6.75	5.92
Accrued Expenses	0.03	0.32	-	0.65	0.71
Short-Term Debt	0	-	-	-	-
Current Portion of Long-Term Debt	0.78	-	-	0.16	0.25
Current Portion of Leases	-	-	-	0.13	0.13
Current Income Taxes Payable	-	-	0.96	0.06	0.06
Current Unearned Revenue	-	-	-	0.13	0.2
Other Current Liabilities	-	0.01	0.01	-	0.01
Total Current Liabilities	0.95	0.59	16.97	7.87	7.27
Long-Term Debt	1.86	2.72	3.03	2.88	0.47
Long-Term Leases	-	-	-	0.29	0.03
Pension & Post-Retirement Benefits	-	-	-	0.44	0.38
Other Long-Term Liabilities	0	0	0.04	0.1	-
Total Liabilities	2.81	3.31	20.05	11.58	8.15

Shareholders' Equity

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	2.79	13.94	13.94	10.97	10.68
Additional Paid-In Capital	4.61	14.61	14.61	17.01	27.99
Retained Earnings	-9.85	-28.11	-24.93	-	-
Comprehensive Income & Other	0	-	-	-18.31	-14.02
Shareholders' Equity	-2.46	0.44	3.61	9.67	24.65
Total Liabilities & Equity	0.35	3.75	23.66	21.24	32.8

Additional Metrics

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	2.64	2.72	3.03	3.46	0.88
Net Cash (Debt)	-2.34	0.83	7.37	10.35	26.55
Net Cash Growth	-	-88.73%	-28.81%	-61.03%	155.77%
Net Cash Per Share	-0.03	0.02	0.21	0.38	1.30
Filing Date Shares Outstanding	69.71	34.85	34.85	34.62	26.89
Total Common Shares Outstanding	69.71	34.85	34.85	27.44	26.71
Working Capital	-0.6	3.09	6.42	12.37	24.56
Book Value Per Share	-0.04	0.01	0.10	0.35	0.92
Tangible Book Value	-2.46	0.44	3.61	9.13	23.89
Tangible Book Value Per Share	-0.04	0.01	0.10	0.33	0.89
Machinery	-	-	-	0.07	0.06

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 2, 2026

Data Sources Report a data error